![](/img/cover-not-exists.png)
Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement
Baig, Nisar A., Taylor, Ronald P., Lindorfer, Margaret A., Church, Amy K., Laplant, Betsy R., Pavey, Emily S., Nowakowski, Grzegorz S., Zent, Clive S.Volume:
53
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2012.681657
Date:
November, 2012
File:
PDF, 436 KB
english, 2012